Traphaco JSC (HOSE:TRA)

Vietnam · Delayed Price · Currency is VND

34,250

-1,150 (-3.25%)

At close: Nov 3, 2026

Market Cap	2.84T +2.5%
Revenue (ttm)	2.79T +13.4%
Net Income	228.56B +13.0%
EPS	3,594.62 +10.2%
Shares Out	82.90M
PE Ratio	9.53
Forward PE	n/a
Dividend	2,000.00 (5.84%)
Ex-Dividend Date	Jul 21, 2026

Volume	1,365
Open	35,850
Previous Close	35,400
Day's Range	34,250 - 35,850
52-Week Range	32,500 - 41,400
Beta	0.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,... [Read more]

Industry Pharmaceutical Preparations

Founded 1972

Employees 1,546

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol TRA

Full Company Profile

Financial Performance

In 2025, Traphaco JSC's revenue was 2.66 trillion, an increase of 13.21% compared to the previous year's 2.35 trillion. Earnings were 216.79 billion, an increase of 4.98%.

Financial Statements